Jeff Herz, M.D.
Chief Executive Officer
View LinkedIn Profile >

Accomplished innovative pharmacologist, Research Program Director and Project Leader with 19 years experience in directing all phases of non-clinical pharmaceutical research and development. Experienced in moving new drugs though all phases of R&D, from discovery research through entry into clinical trials. Responsible for scientific oversight, execution, analysis and reporting of multiple concurrent in vitro, ex vivo and in vivo studies conducted in-house, outsourced to CROs and academic collaborations. Inventor of 56 issued and allowed pharmaceutical technology patents in multiple therapeutic areas. Goal oriented, attention to detail and proven ability to work in an interdisciplinary team. Trusted by senior management to provide scientific leadership and strategic advice for company critical efforts.

Highlights include:

  • Molecular Pharmacology
  • Assay Development
  • HTS
  • Animal Models and Pharmacology
  • Physiology
  • Integrated Drug Development
  • Patents and Intellectual Property Management


Bill Thompson

Director of Pharmacology
View LinkedIn Profile >

Pharmacologist with over 25 years of pharmaceutical drug discovery and development experience with emphasis on target validation, assay development, SAR/lead optimization/preclinical development support, translational pharmacology and preclinical project management.

Highlights include drug discovery and development expertise in multiple therapeutic areas including:

  • CNS diseases (depression, schizophrenia, anxiety, sleep, arousal, migraine)
  • Metabolic/endocrine diseases (obesity, type II diabetes, hyperthyroidism, osteoporosis)
  • Cardiovascular diseases (hypertension, CAD, CHF, PAH)
  • Immune diseases (inflammation and autoimmune)
  • Pain (inflammatory and neuropathic)
  • Renal diseases
  • Cancer


Ed Kesicki
Director of Chemistry

Highlights include:

  • Chemistry and Pharmaceutical Consulting
  • Drug Discovery and Development
  • Medicinal Chemistry